Introduction
Artificial intelligence is presently a central driver in the transformation of healthcare, refining the accuracy of diagnostic interpretation, augmenting the rigor of clinical reasoning, and personalizing therapeutic pathways according to the distinctive genomic, phenotypic, and psychosocial profiles of each patient [1]. Sustained growth in data volume—from genomic sequences to wearable-device readings—together with mounting complexity in multimodal treatment protocols, necessitates the utilisation of sophisticated yet scalable analytical frameworks [2]. AI now stands as the foremost catalyst driving advances in the discipline. Supervised learning architectures, natural language processing pipelines, and risk-prediction algorithms—when thoughtfully integrated—permit clinicians to arrive at therapeutic choices that are not only timelier and more accurate but also bespoke to the individual patient profile [3]. This review delineates the principal domains in which AI is recalibrating bedside decision-making, quantifies the resultant clinical and systemic efficiencies, identifies the prevailing barriers to widespread adoption, and forecasts the progressive refinement of AI-guided healthcare systems.
AI in Diagnostics and Early Detection
One of the most significant contributions of AI in healthcare is its ability to improve diagnostic accuracy. AI-powered tools, particularly in medical imaging, have demonstrated remarkable success in detecting diseases such as cancer, cardiovascular conditions, and neurological disorders.
- Radiology and Imaging:AI algorithms, profound learning models, analyze X-rays, MRIs, and CT scans with precision comparable to or exceeding human radiologists [4] (Topol, 2019). For example, Google’s DeepMind developed an AI system that detects over 50 eye diseases from retinal scans with 94% accuracy [5] (De Fauw et al., 2018).
- Pathology:AI assists in identifying cancerous tissues in histopathology slides, reducing diagnostic errors. A study by Esteva et al. demonstrated that AI can classify skin cancer with the same accuracy as dermatologists [6].
- Early Disease Prediction:AI models analyze electronic health records (EHRs) and biomarkers to predict diseases like sepsis, diabetes, and Alzheimer’s before symptoms manifest [7].
Personalized Treatment and Precision Medicine
AI enables precision medicine by tailoring treatments based on individual patient data, including genetics, lifestyle, and environmental factors.
- Genomics and Drug Development:AI accelerates genomic analysis, identifying mutations and suggesting targeted therapies. IBM Watson for Oncology, for instance, provides evidence-based cancer treatment recommendations [8].
- Predictive Analytics for Treatment Response:Machine learning models predict how patients will respond to specific medications, reducing trial-and-error prescribing. A study by Shimabukuro et al. demonstrated that AI could predict sepsis treatment outcomes with 85% accuracy [9].
Keywords: Non-communicable Diseases; NCD; Public Health; Pakistan
Corresponding author: Syed Alfakhar Ali Shah
Mail: alfakharali93kk@gmail.com
Enhancing Clinical Workflow and Reducing Physician Burnout
Physician burnout, often caused by administrative burdens and information overload, is a growing concern. AI alleviates this by automating routine tasks and streamlining workflows.
- Natural Language Processing (NLP) for EHRs:AI extracts relevant data from unstructured clinical notes, reducing documentation time. Tools like Amazon Comprehend Medical and OpenAI’s GPT-4 assist in summarizing patient records [10].
- Virtual Health Assistants:AI chatbots (e.g., Buoy Health, Ada) triage patient symptoms, reducing unnecessary hospital visits.
- Automated Scheduling and Resource Allocation:AI optimizes hospital operations, predicting patient admissions and staffing needs [11].
Challenges and Ethical Considerations
Despite its potential, AI integration in clinical decision-making faces several challenges:
- Data Privacy and Security:AI relies on vast datasets, raising concerns about patient confidentiality under regulations like HIPAA and GDPR [12].
- Bias and Generalizability:AI models trained on non-diverse datasets may exhibit racial or gender biases (Obermeyer et al., 2019).
- Regulatory and Liability Issues:Determining accountability for AI-driven errors remains unresolved (FDA, 2021).
- Physician Trust and Adoption:Clinicians may resist AI due to alack of transparency (“black box” problem) or fear of job displacement [13].
Future Directions
The future of AI in clinical decision-making includes:
- Explainable AI (XAI):Developing interpretable models to enhance clinician trust.
- Federated Learning:Enabling collaborative AI training across institutions without sharing raw data.
- Integration with Wearables and IoT:Real-time monitoring through AI-powered devices for proactive care.
Conclusion
AI is transforming clinical decision-making by enhancing diagnostics, personalizing treatments, and improving workflow efficiency. While challenges like data privacy, bias, and regulatory hurdles persist, ongoing advancements in explainable AI and federated learning promise a more integrated and ethical future. As AI continues to evolve, its role in bridging healthcare delivery gaps will become increasingly indispensable.
Declaration:
Ethical approval
Ethics approval was not required for this review.
Consent
Informed consent was not required for this review.
Sources of funding
No funding was acquired for this paper.
Author’s contribution
All author contributed to finalize this manuscript
Conflicts of interest disclosure
The authors declare that there is no conflict of interest.
Data availability statement
It will be available on reasonable request.
References
1.Bajwa J, Munir U, Nori A, Williams B. Artificial intelligence in healthcare: transforming the practice of medicine. Future healthcare journal. 2021 Jul 1;8(2):e188-94.
2.Nadeem M, Kostic S, Dornhöfer M, Weber C, Fathi M. A comprehensive review of digital twin in healthcare in the scope of simulative health-monitoring. Digital Health. 2025 Jan;11:20552076241304078.
3.Oei SP, Bakkes TH, Mischi M, Bouwman RA, van Sloun RJ, Turco S. Artificial intelligence in clinical decision support and the prediction of adverse events. Frontiers in Digital Health. 2025 May 30;7:1403047.
4.DuBois KN. Deep medicine: how artificial intelligence can make healthcare human again. Perspectives on Science and Christian Faith. 2019 Sep 1;71(3):199-201.
5.De Fauw J, Ledsam JR, Romera-Paredes B, Nikolov S, Tomasev N, Blackwell S, Askham H, Glorot X, O’Donoghue B, Visentin D, Van Den Driessche G. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nature medicine. 2018 Sep;24(9):1342-50.
6.Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. nature. 2017 Feb 2;542(7639):115-8.
7.Rajkomar A, Oren E, Chen K, Dai AM, Hajaj N, Hardt M, Liu PJ, Liu X, Marcus J, Sun M, Sundberg P. Scalable and accurate deep learning with electronic health records. NPJ digital medicine. 2018 May 8;1(1):18.
8.Zhou N, Zhang CT, Lv HY, Hao CX, Li TJ, Zhu JJ, Zhu H, Jiang M, Liu KW, Hou HL, Liu D. Concordance study between IBM Watson for oncology and clinical practice for patients with cancer in China. The oncologist. 2019 Jun 1;24(6):812-9.
9.Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, Ramirez BI, Sánchez-Guirales SA, Simon JA, Tomietto G, Rapti C. Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine. Pharmaceutics. 2024 Oct 14;16(10):1328.
10.Lee C, Vogt KA, Kumar S. Prospects for AI clinical summarization to reduce theburden of patient chart review. Frontiers in Digital Health. 2024 Nov 7;6:1475092.
11.Maleki Varnosfaderani S, Forouzanfar M. The role of AI in hospitals and clinics: transforming healthcare in the 21st century. Bioengineering. 2024 Mar 29;11(4):337.
12.Jangid P, Meena A, Prerna R, Hashmi ZH, Kumar V, Bhagtani H. The Role of Artificial Intelligence in Safeguarding Patient Privacy in Healthcare Systems. Journal of Pharmacy and Bioallied Sciences. 2025 Jun 1;17(Suppl 2):S1083-5.
13.Khan B, Fatima H, Qureshi A, Kumar S, Hanan A, Hussain J, Abdullah S. Drawbacks of artificial intelligence and their potential solutions in the healthcare sector. Biomedical Materials & Devices. 2023 Sep;1(2):731-8.
